Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($1,348.0M) | ($4,290.0M) | ($19.7B) | ($12.3B) | ($6,448.0M) | $4,058.0M | $16.0B | ($4,394.0M) | ($13.0B) | ($7,215.0M) | ($12.4B) | $3,577.0M | $12.1B | ($3,500.0M) | $1,086.0M | $43.6B | $27.6B | $5,929.0M | $8,731.0M | $59.2B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Pfizer Inc.'s last 12-month Net Debt is $57.7B, based on the financial report for Sep 29, 2024 (Q3 2024).
Over the last year, Pfizer Inc.'s Net Debt growth was 197.4%. The average annual Net Debt growth rates for Pfizer Inc. have been 30.4% over the past three years, 5.8% over the past five years.
Over the last year, Pfizer Inc.'s Net Debt growth was 197.4%, which is higher than industry growth of 0.3%. It indicates that Pfizer Inc.'s Net Debt growth is Bad.